Various
subtypes of immunocytes react against implanted biomaterials
to eliminate the foreign body object from the host’s body.
Among these cells, dendritic cells (DCs) play a key role in early
immune response, later engaging lymphocytes through antigens presentation.
Due to their capability to induce tolerogenic or immunogenic
responses, DCs have been considered as key therapeutic targets for
immunomodulatory products. For instance, tolerogenic DCs are
applied in the treatment of autoimmune diseases, rejection of allograft
transplantation, and implanted biomaterial. Due to the emerging importance
of DCs in immunomodulatory biomaterials, this Review summarizes
DCs’ responsessuch as adhesion, migration, and maturationto
biomaterials. We also review some examples of key molecules and their
applications in DCs’ immunoengineering. These evaluations
would pave the way for designing advanced biomaterials and nanomaterials
to modulate the immune system, applicable in tissue engineering, transplantation,
and drug delivery technologies.